Hyperlipidemic hypersensitivity to lethal microbial inflammation and its reversal by selective targeting of nuclear transport shuttles

Abstract Hyperlipidemia, the hallmark of Metabolic Syndrome that afflicts millions of people worldwide, exacerbates life-threatening infections. We present a new evidence for the mechanism of hyperlipidemic hypersensitivity to microbial inflammation caused by pathogen-derived inducer, LPS. We demons...

Full description

Bibliographic Details
Main Authors: Yan Liu, Jozef Zienkiewicz, Kelli L. Boyd, Taylor E. Smith, Zhi-Qi Xu, Jacek Hawiger
Format: Article
Language:English
Published: Nature Portfolio 2021-06-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-021-91395-w
_version_ 1818424530788417536
author Yan Liu
Jozef Zienkiewicz
Kelli L. Boyd
Taylor E. Smith
Zhi-Qi Xu
Jacek Hawiger
author_facet Yan Liu
Jozef Zienkiewicz
Kelli L. Boyd
Taylor E. Smith
Zhi-Qi Xu
Jacek Hawiger
author_sort Yan Liu
collection DOAJ
description Abstract Hyperlipidemia, the hallmark of Metabolic Syndrome that afflicts millions of people worldwide, exacerbates life-threatening infections. We present a new evidence for the mechanism of hyperlipidemic hypersensitivity to microbial inflammation caused by pathogen-derived inducer, LPS. We demonstrate that hyperlipidemic animals succumbed to a non-lethal dose of LPS whereas normolipidemic controls survived. Strikingly, survival of hyperlipidemic animals was restored when the nuclear import of stress-responsive transcription factors (SRTFs), Sterol Regulatory Element-Binding Proteins (SREBPs), and Carbohydrate-Responsive Element-Binding Proteins (ChREBPs) was impeded by targeting the nuclear transport checkpoint with cell-penetrating, biselective nuclear transport modifier (NTM) peptide. Furthermore, the burst of proinflammatory cytokines and chemokines, microvascular endothelial injury in the liver, lungs, heart, and kidneys, and trafficking of inflammatory cells were also suppressed. To dissect the role of nuclear transport signaling pathways we designed and developed importin-selective NTM peptides. Selective targeting of the importin α5, ferrying SRTFs and ChREBPs, protected 70–100% hyperlipidemic animals. Targeting importin β1, that transports SREBPs, was only effective after 3-week treatment that lowered blood triglycerides, cholesterol, glucose, and averted fatty liver. Thus, the mechanism of hyperlipidemic hypersensitivity to lethal microbial inflammation depends on metabolic and proinflammatory transcription factors mobilization, which can be counteracted by targeting the nuclear transport checkpoint.
first_indexed 2024-12-14T13:59:31Z
format Article
id doaj.art-5a9a67ba778d477782a1456528d9f96b
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-12-14T13:59:31Z
publishDate 2021-06-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-5a9a67ba778d477782a1456528d9f96b2022-12-21T22:58:44ZengNature PortfolioScientific Reports2045-23222021-06-0111111710.1038/s41598-021-91395-wHyperlipidemic hypersensitivity to lethal microbial inflammation and its reversal by selective targeting of nuclear transport shuttlesYan Liu0Jozef Zienkiewicz1Kelli L. Boyd2Taylor E. Smith3Zhi-Qi Xu4Jacek Hawiger5Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University School of MedicineDivision of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University School of MedicineDepartment of Pathology, Microbiology and Immunology, Vanderbilt University School of MedicineDivision of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University School of MedicineDivision of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University School of MedicineDivision of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University School of MedicineAbstract Hyperlipidemia, the hallmark of Metabolic Syndrome that afflicts millions of people worldwide, exacerbates life-threatening infections. We present a new evidence for the mechanism of hyperlipidemic hypersensitivity to microbial inflammation caused by pathogen-derived inducer, LPS. We demonstrate that hyperlipidemic animals succumbed to a non-lethal dose of LPS whereas normolipidemic controls survived. Strikingly, survival of hyperlipidemic animals was restored when the nuclear import of stress-responsive transcription factors (SRTFs), Sterol Regulatory Element-Binding Proteins (SREBPs), and Carbohydrate-Responsive Element-Binding Proteins (ChREBPs) was impeded by targeting the nuclear transport checkpoint with cell-penetrating, biselective nuclear transport modifier (NTM) peptide. Furthermore, the burst of proinflammatory cytokines and chemokines, microvascular endothelial injury in the liver, lungs, heart, and kidneys, and trafficking of inflammatory cells were also suppressed. To dissect the role of nuclear transport signaling pathways we designed and developed importin-selective NTM peptides. Selective targeting of the importin α5, ferrying SRTFs and ChREBPs, protected 70–100% hyperlipidemic animals. Targeting importin β1, that transports SREBPs, was only effective after 3-week treatment that lowered blood triglycerides, cholesterol, glucose, and averted fatty liver. Thus, the mechanism of hyperlipidemic hypersensitivity to lethal microbial inflammation depends on metabolic and proinflammatory transcription factors mobilization, which can be counteracted by targeting the nuclear transport checkpoint.https://doi.org/10.1038/s41598-021-91395-w
spellingShingle Yan Liu
Jozef Zienkiewicz
Kelli L. Boyd
Taylor E. Smith
Zhi-Qi Xu
Jacek Hawiger
Hyperlipidemic hypersensitivity to lethal microbial inflammation and its reversal by selective targeting of nuclear transport shuttles
Scientific Reports
title Hyperlipidemic hypersensitivity to lethal microbial inflammation and its reversal by selective targeting of nuclear transport shuttles
title_full Hyperlipidemic hypersensitivity to lethal microbial inflammation and its reversal by selective targeting of nuclear transport shuttles
title_fullStr Hyperlipidemic hypersensitivity to lethal microbial inflammation and its reversal by selective targeting of nuclear transport shuttles
title_full_unstemmed Hyperlipidemic hypersensitivity to lethal microbial inflammation and its reversal by selective targeting of nuclear transport shuttles
title_short Hyperlipidemic hypersensitivity to lethal microbial inflammation and its reversal by selective targeting of nuclear transport shuttles
title_sort hyperlipidemic hypersensitivity to lethal microbial inflammation and its reversal by selective targeting of nuclear transport shuttles
url https://doi.org/10.1038/s41598-021-91395-w
work_keys_str_mv AT yanliu hyperlipidemichypersensitivitytolethalmicrobialinflammationanditsreversalbyselectivetargetingofnucleartransportshuttles
AT jozefzienkiewicz hyperlipidemichypersensitivitytolethalmicrobialinflammationanditsreversalbyselectivetargetingofnucleartransportshuttles
AT kellilboyd hyperlipidemichypersensitivitytolethalmicrobialinflammationanditsreversalbyselectivetargetingofnucleartransportshuttles
AT tayloresmith hyperlipidemichypersensitivitytolethalmicrobialinflammationanditsreversalbyselectivetargetingofnucleartransportshuttles
AT zhiqixu hyperlipidemichypersensitivitytolethalmicrobialinflammationanditsreversalbyselectivetargetingofnucleartransportshuttles
AT jacekhawiger hyperlipidemichypersensitivitytolethalmicrobialinflammationanditsreversalbyselectivetargetingofnucleartransportshuttles